| Literature DB >> 23896471 |
Duncan Wilson1, Betty Hebecker, David L Moyes, Pedro Miramón, Nadja Jablonowski, Stephanie Wisgott, Stefanie Allert, Julian R Naglik, Bernhard Hube.
Abstract
The pathology of vulvovaginal candidiasis (VVC) caused by Candida albicans is associated with a nonprotective inflammatory response and is frequently treated with clotrimazole. We investigated the mechanisms by which clotrimazole resolves VVC. Low levels of clotrimazole, which do not block fungal growth, inhibit expression of a "danger response" transcription factor, c-Fos, block production of proinflammatory cytokines, and inhibit neutrophil infiltration to the site of infection.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23896471 PMCID: PMC3811401 DOI: 10.1128/AAC.01244-13
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191